메뉴 건너뛰기




Volumn 26, Issue 8, 2011, Pages 1303-1310

Continuous EPO receptor activator therapy of anemia in children under peritoneal dialysis

Author keywords

Anemia; CERA; Children; EPO; Erythropoietin; Peritoneal dialysis

Indexed keywords

HEMOGLOBIN; PEGINESATIDE;

EID: 80052485523     PISSN: 0931041X     EISSN: 1432198X     Source Type: Journal    
DOI: 10.1007/s00467-011-1846-5     Document Type: Article
Times cited : (22)

References (28)
  • 3
    • 0141954949 scopus 로고    scopus 로고
    • Morbidity and mortality in children with anemia at initiation of dialysis
    • DOI 10.1007/s00467-003-1214-1
    • Warady B, Ho M (2003) Morbidity and mortality in children with anemia at initiation of dialysis. Pediatr Nephrol 18:1055-1062. (Pubitemid 37236222)
    • (2003) Pediatric Nephrology , vol.18 , Issue.10 , pp. 1055-1062
    • Warady, B.A.1    Ho, M.2
  • 4
    • 0023120533 scopus 로고
    • Correction of the anemia of end-stage renal disease with recombinant human erythropoietin
    • Eschbach JW, Egrie JC, Downing MR, Browne JK, Admson JW (1987) Correction of the anemia of end-stage renal disease with recombinant human erythropoietin. N Engl J Med 316:73-78.
    • (1987) N Engl J Med , vol.316 , pp. 73-78
    • Eschbach, J.W.1    Egrie, J.C.2    Downing, M.R.3    Browne, J.K.4    Admson, J.W.5
  • 5
    • 33750522840 scopus 로고    scopus 로고
    • Clinical practice guidelines for anemia in chronic kidney diseases
    • National Kidney Foundation, KDOKI
    • National Kidney Foundation, KDOKI (2006) Clinical practice guidelines for anemia in chronic kidney diseases. Am J Kidney Dis 47:s1-s14.
    • (2006) Am J Kidney Dis , vol.47
  • 9
    • 0037228098 scopus 로고    scopus 로고
    • Effect of variability in anemia management on hemoglobin outcomes in ESRD
    • DOI 10.1053/ajkd.2003.50030
    • Lacson E Jr, Ofsthun N, Lazarus JM (2003) Effect of variability in anemia management on hemoglobin outcomes in ESRD. Am J Kidney Dis 41:111-124. (Pubitemid 36043358)
    • (2003) American Journal of Kidney Diseases , vol.41 , Issue.1 , pp. 111-124
    • Lacson Jr., E.1    Ofsthun, N.2    Lazarus, J.M.3
  • 10
    • 32644457068 scopus 로고    scopus 로고
    • Hemoglobin cycling in hemodialysis patients treated with recombinant human erythropoietin
    • DOI 10.1111/j.1523-1755.2005.00532.x, PII 4494716
    • Fishbane S, Berns JS (2005) Hemoglobin cycling in hemodialysis patients treated with recombinant human erythropoietin. Kidney Int 68:1337-1343. (Pubitemid 43246455)
    • (2005) Kidney International , vol.68 , Issue.3 , pp. 1337-1343
    • Fishbane, S.1    Berns, J.S.2
  • 13
    • 0037317083 scopus 로고    scopus 로고
    • Treatment of anaemia in dialysis patients with unit dosing of darbepoetin alfa at a reduced dose frequency relative to recombinant human erythropoietin (rHuEpo)
    • DOI 10.1093/ndt/18.2.362
    • Locatelli F, Canaud B, Giacardy F, Martin-Malo A, Baker N, Wilson J (2003) Treatment of anaemia in dialysis patients with unit dosing of darbepoetin alfa at a reduced dose frequency relative to recombinant human erythropoietin (rHuEpo). Nephrol Dial Transplant 18:362-369. (Pubitemid 36181689)
    • (2003) Nephrology Dialysis Transplantation , vol.18 , Issue.2 , pp. 362-369
    • Locatelli, F.1    Canaud, B.2    Giacardy, F.3    Martin-Malo, A.4    Baker, N.5    Wilson, J.6
  • 14
    • 2442702016 scopus 로고    scopus 로고
    • Darbepoetin alfa effectively maintains haemoglobin concentrations at extended dose intervals relative to intravenous or subcutaneous recombinant human erythropoietin in dialysis patients
    • DOI 10.1093/ndt/gfh106
    • Brunkhorst R, Bommer J, Braun J, Haag-Weber M, Gill C, Wagner J, Wagener T, German Aranesp Study Group (2004) Darbepoetin alfa effectively maintains hemoglobin concentrations at extended dose intervals relative to intravenous or subcutaneous recombinant human erythropoietin in dialysis patients. Nephrol Dial Transplant 19:1224-1230. (Pubitemid 38655907)
    • (2004) Nephrology Dialysis Transplantation , vol.19 , Issue.5 , pp. 1224-1230
    • Brunkhorst, R.1    Bommer, J.2    Braun, J.3    Haag-Weber, M.4    Gill, C.5    Wagner, J.6    Wagener, T.7
  • 17
    • 31644439003 scopus 로고    scopus 로고
    • Darbepoetin alfa (Aranesp) in children with chronic renal failure
    • DOI 10.1111/j.1523-1755.2005.00592.x, PII 4494778
    • Geary DF, Keating LE, Vigneux A, Stephens D, Hébert D, Harvey EA (2005) Darbepoetin alfa (Aranesp) in children with chronic renal failure. Kidney Int 68:1759-1765. (Pubitemid 43169920)
    • (2005) Kidney International , vol.68 , Issue.4 , pp. 1759-1765
    • Geary, D.F.1    Keating, L.E.2    Vigneux, A.3    Stephens, D.4    Hebert, D.5    Harvey, E.A.6
  • 18
    • 43749117511 scopus 로고    scopus 로고
    • Methoxy polyethylene glycol-epoetin beta: A review of its use in the management of anaemia associated with chronic kidney disease
    • DOI 10.2165/00003495-200868080-00009
    • Curran MP, McCormack P (2008) Methoxy polyethylen glycolepoetin beta. A review of its use in the management of anaemia associated with chronic kidney disease. Drugs 68:1139-1156. (Pubitemid 351693680)
    • (2008) Drugs , vol.68 , Issue.8 , pp. 1139-1156
    • Curran, M.P.1    McCormack, P.L.2
  • 19
    • 36249017329 scopus 로고    scopus 로고
    • Efficacy of intravenous methoxy polyethylene glycol-epoetin beta administered every 2 weeks compared with epoetin administered 3 times weekly in patients treated by hemodialysis or peritoneal dialysis: A randomized trial
    • DOI 10.1053/j.ajkd.2007.08.013, PII S0272638607011973
    • Klinger M, Arias M, Vargemezis V, Besarab A, Sulowicz W, Gernthotlz T, Ciechanowski K, Dougherty FC, Beyer U (2007) Efficacy of intravenous methoxy polyethylene glycol-epoetin beta administered every 2 weeks compared with epoetin administered 3 times weekly in patients treated by hemodialysis or peritoneal dialysis: a randomized trial. Am J Kidney Dis 50:989-1000. (Pubitemid 350122810)
    • (2007) American Journal of Kidney Diseases , vol.50 , Issue.6 , pp. 989-1000
    • Klinger, M.1    Arias, M.2    Vargemezis, V.3    Besarab, A.4    Sulowicz, W.5    Gerntholtz, T.6    Ciechanowski, K.7    Dougherty, F.C.8    Beyer, U.9
  • 20
    • 38349014009 scopus 로고    scopus 로고
    • C.E.R.A. maintains stable control of hemoglobin in patients with chronic kidney disease on dialysis when administered once every two weeks
    • RUBRA Study Investigators
    • Spinowitz B, Coyne D, Lok Ch, Fraticelli M, Azer M, Dalal S, Villa G, Rosansky S, Adamis H, Beyer U, RUBRA Study Investigators (2008) C.E.R.A. maintains stable control of hemoglobin in patients with chronic kidney disease on dialysis when administered once every two weeks. Am J Nephrol 28:280-289.
    • (2008) Am J Nephrol , vol.28 , pp. 280-289
    • Spinowitz, B.1    Coyne, D.2    Lok, C.3    Fraticelli, M.4    Azer, M.5    Dalal, S.6    Villa, G.7    Rosansky, S.8    Adamis, H.9    Beyer, U.10
  • 23
    • 34548207889 scopus 로고    scopus 로고
    • Once-monthly subcutaneous C.E.R.A. maintains stable hemoglobin control in patients with chronic kidney disease on dialysis and converted directly from epoetin one to three times weekly
    • Sulowicz W, Locatelli F, Ryckelynck J, Balla J, Csiky B, Harris K, Ehrhard P, Beyer U (2007) Once-monthly subcutaneous C.E.R.A. maintains stable hemoglobin control in patients with chronic kidney disease on dialysis and converted directly from epoetin one to three times weekly. Clin J Am Soc Nephrol 2:637-646.
    • (2007) Clin J Am Soc Nephrol , vol.2 , pp. 637-646
    • Sulowicz, W.1    Locatelli, F.2    Ryckelynck, J.3    Balla, J.4    Csiky, B.5    Harris, K.6    Ehrhard, P.7    Beyer, U.8
  • 28
    • 33750014056 scopus 로고    scopus 로고
    • Accessed 20 January 2011
    • Scientific Discussion http://www.emea.europa.eu/docs/en-GB/document- library/EPAR-Scientific-Discussion/human/000739/WC500033669.pdf. Accessed 20 January 2011.
    • Scientific Discussion


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.